View
| CBA 2019 Workshop Series: Challenges and future prospects: CNS drug development Date and Time: 1:30 – 5:00 pm, Sunday, March 17, 2019 Venue: Stanford University, Graduate Community Center, Havana Room 750 Escondido Road, Palo Alto, CA 94305Sunday, March 17, 2019 |
|
|---|---|
| 1:30 – 2:00 pm | Registration |
| 2:00 – 2:05 pm | Opening remark Dr. Dannis Chang |
| 2:05-2:40pm | ApoE4 as A Drug Target for Alzheimer’s Disease Dr. Yadong Huang Director and senior investigator of the Gladstone Center for Translational Advancement at the Gladstone Institutes and Professor at the Departments of Neurology and Pathology, University of California, San Francisco. |
| 2:40 – 3:15 pm | Craniofacial Analgesic Effect of Nasal Application of a Novel Formulation of Oxytocin Dr. David Yeomans Associate Professor at Department of Anesthesia, Stanford University |
| 3:15 – 3:30 pm | Break |
| 3:30 – 4:05 pm | CNS Drug Discovery Using iPSCs Derived Neural Cell Models Dr. Tao Huang Co-founder and President, NeuCyte, Inc. |
| 4:05 – 4:40 pm | A History of CNS drugs Dr. Jie Jack Li Medicinal Chemist, Revolution Medicines |
| 4:40 – 5:00pm | Networking |
Event Information
Event Topic:
CBA 2019 Workshop Series: Challenges and future prospects: CNS drug development
Event Description:
https://www.eventbrite.com/e/cba-2019-march-symposium-of-cns-drug-discovery-tickets-58393340052?aff=eac2
Date/Time:
Date(s) - 03/17/19
1:30 pm - 5:00 pm
Event Location:
Other: Stanford University, Graduate Community Center, Havana Room 750 Escondido Road, Palo Alto, CA 94305
Event Details
Event Type
Symposium